Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02533323Phase 2Terminated
P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens
Lymphoma, Extranodal NK-T-Cell
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Hematological Oncology, Sun Yat-sen University Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stefano Luminari, MD

Ematologia, AUSL IRCCS Reggio Emilia

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Wyndham H Wilson, M.D.

National Cancer Institute (NCI)

Moderately Similar
7 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

ZhongJun Xia, MD/PHD

Department of Hematological Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China,

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell

Worked with same sponsors:

Sun Yat-sen University
Similarity Score30%

Weili Zhao, MD

Shanghai Rui Jin Hospital,Shanghai Jiao Tong University - School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Helen Heslop, MD

Baylor College of Medicine

Moderately Similar
17 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

James N Kochenderfer, M.D.

National Cancer Institute (NCI)

Moderately Similar
11 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Jinhua Liang

he First Affiliated Hospital with Nanjing Medical University, Nanjing, China

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Pablo Ortiz, MD, PhD

Hospital 12 de Octubre

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Ting Liu, MD

West China Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Kurt Gunter, MD

Cell Medica

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02533323Phase 2PrincipalInvestigator

P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

Lymphoma, Extranodal NK-T-Cell
Terminated

All 1 trials loaded